Price: $9.19
(as of Sep 13,2024 21:34:49 UTC – Details)
From the Publisher
Get Slim, Get Organized, Get the Wegovy Journal—Your Health Will Thank You!
192 pages dedicated to your daily Wegovy journey – a full 3 months of focused health tracking!
Weekly wins, measured and celebrated—track your progress and triumphs on our reflection pages! (12 Weeks)
Keep your emergency contacts close at hand ( 1 Page) / Track and cheer your 12-week weight loss milestones( 1 Page)
Organize your medical visits with this handy appointment log ( 2 Pages) / Detail your doctor visits here for comprehensive health tracking( 6 Pages)
Your wellness, your story – track it beautifully in the Wegovy Journal.
Unlock Your Health Transformation: Start a 12-week journey to better health with the “Wegovy Journal.”
Tailored Design: Specifically designed for individuals using GLP-1 medications such as Wegovy, Mounjaro, and Ozempic.Multi-purpose Planner: Ideal for those looking to lose weight, monitor medication effects, and keep detailed dietary records.Comprehensive Features:Tailored for a 3-month health and weight loss journey with structured and achievable goals. Compatible with various GLP-1 agonists, providing versatility for users of these medications. Includes comprehensive symptom checklists to monitor your body’s response. Features dedicated sections for detailed doctor’s appointment notes. Contains goal-setting pages for tracking weight and body measurements. Integrates a calorie counter for effective diet management. Encourages consistent tracking of medication dosages.Substantial Content: Contains 216 pages of thoughtfully designed features to support health and wellness goals.
Take control of your health journey today! Add the ‘Wegovy Journal’ to your cart and start your transformation with confidence and clarity.
ASIN : B0D3BKX23W
Publisher : Independently published (May 2, 2024)
Language : English
Paperback : 216 pages
Reading age : 16 – 18 years
Item Weight : 1.08 pounds
Dimensions : 7 x 0.49 x 10 inches
Reviews
There are no reviews yet.